Palisade Capital Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,000
Closed -$200K 428
2019
Q2
$200K Sell
3,000
-1,250
-29% -$95.2K 0.01% 403
2019
Q1
$405K Sell
4,250
-1,300
-23% -$162K 0.01% 379
2018
Q4
$689K Buy
5,550
+2,050
+59% +$338K 0.03% 360
2018
Q3
$854K Buy
+3,500
New +$809K 0.02% 375

Other funds holding INGN

Palisade Capital Management's INGN Position: Q3 2019 in Review

Palisade Capital Management sold out of Inogen (INGN) in Q3 2019, closing a stake of 3,000 shares — an estimated $200K sold.

Palisade Capital Management first reported a position in INGN in Q3 2018 and held it in 4 quarters. The position peaked at $854K in Q3 2018. 176 funds tracked by Wall St. Rank hold INGN as of Q3 2019.

  • Palisade Capital Management reported no remaining Inogen position as of Q3 2019 after selling out during the quarter.
  • Palisade Capital Management sold 3,000 Inogen shares in Q3 2019, an estimated $200K.
  • Palisade Capital Management first reported a position in Inogen in Q3 2018 and held it in 4 quarters.
  • Palisade Capital Management's Inogen position peaked at $854K in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Inogen as of Q3 2019.

Based on Palisade Capital Management's 13F filing for Q3 2019, filed 6 Nov 2019.